...

Pharmaceutical-grade peptides & lab-use compounds available online.

Free US shipping for orders above $600

This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals.

Semaglutide:Metabolic & Weight Support

$40.00

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that plays a crucial role in managing blood sugar levels, weight regulation, and cardiovascular health. Originally developed as a treatment for type 2 diabetes, semaglutide has gained significant attention for its additional benefits, including weight loss and potential neuroprotective effects.

Specifications Price
500mcg*25pcs $40.00
  • Our Support Team

HPLS
Testing

Endotoxin
Assay

TAMC
Test

TYMC
Test

Heavy Metal
Screening

Characteristic Details
Molecular Formula C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight 4113.641g/mol
CAS Number  910463-68-2

Semaglutide works by activating GLP-1 receptors:

  • Promote insulin secretion (blood sugar dependence, reduce the risk of hypoglycemia)
  • Inhibit glucagon secretion (reduce liver glucose output)
  • Delay gastric emptying (increase satiety, reduce food intake)
  • Regulate the hypothalamic appetite center (reduce hunger)

Blood Sugar Control
Semaglutide stimulates insulin release when blood sugar levels are high, helping prevent spikes and maintain stable glucose levels.
Weight Management
By reducing appetite and promoting a feeling of fullness, Semaglutide can assist with weight loss, making it an option for people struggling with obesity or overweight-related conditions.
Cardiovascular Health
Clinical studies suggest that Semaglutide may reduce the risk of cardiovascular events like heart attack and stroke in patients with type 2 diabetes.

Hypoglycemic effect (type 2 diabetes):It can reduce HbA1c (glycosylated hemoglobin) by 1.5%~2.1% (SUSTAIN trial).
Cardiovascular benefits: In high-risk type 2 diabetes patients, the risk of major adverse cardiovascular events (MACE) was significantly reduced by 26% (SUSTAIN-6 trial).
Weight loss effect (obesity)
In the STEP clinical trial, the average weight loss of obese/overweight patients (without diabetes) was:

  • (2.4mg/week): 15%~18% (about 15-20kg)
  • Some patients lost more than 20% (close to the effect of bariatric surgery).

All product is sold solely for scientific research purposes. Researchers are responsible for ensuring compliance with local regulations and institutional guidelines. Keep out of reach of children and unauthorized personnel.

Your Reliable Source for High-Quality Research Peptides

1688pharma is more than just a trusted supplier of research peptides. We are committed to scientific advancement, dedicated to providing the highest quality pharmaceutical-grade compounds that empower researchers and clients to achieve their goals.

Unparalleled Quality

Our proprietary processes and meticulous sourcing of premium materials ensure that every peptide we offer meets the most stringent pharmaceutical standards with verified 99% purity.

Independently Verified

Every peptide undergoes rigorous third-party laboratory testing using advanced techniques like HPLC, LC-MS, and NMR. Complete Certificates of Analysis available for transparency and verification.

Fast Shipping & Support

We provide expedited worldwide shipping with reliable tracking and discreet packaging. Our dedicated customer support team assists with orders, storage guidelines, and product inquiries promptly.